CNL and aCML should be considered as single entity based on molecular profiles and outcomes.
Carreño-Tarragona G. et al, (2022), Blood Adv
Human bone marrow organoids for disease modelling, discovery and validation of therapeutic targets in hematological malignancies.
Khan AO. et al, (2022), Cancer Discov
Single-cell methods in myeloproliferative neoplasms - old questions, new technologies.
O'Sullivan JM. et al, (2022), Blood
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.
Bueno C. et al, (2022), Blood, 140, 38 - 44
A tale of two alleles: TP53 and transformation in MPNs.
Brierley C. and Psaila B., (2022), Blood, 139, 3567 - 3568
In utero origin of myelofibrosis presenting in adult monozygotic twins.
Sousos N. et al, (2022), Nat Med, 28, 1207 - 1211
HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.
Li L. et al, (2022), Blood, 139, 2797 - 2815
The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy.
Strickland M. et al, (2022), Br J Haematol, 196, 1149 - 1158
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro.
Liu Z-J. et al, (2022), Blood Adv, 6, 13 - 27
Single-Cell Multi-Omics Reveals the Genetic, Cellular and Molecular Landscape of TP53 Mutated Leukemic Transformation in MPN
Rodriguez-Meira A. et al, (2021), BLOOD, 138
Message in a platelet: decoding platelet transcriptomes in myeloproliferative neoplasms.
Shapiro S. et al, (2021), Cell Rep Med, 2
Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development.
Roy A. et al, (2021), Cell Rep, 36
Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia.
Iskander D. et al, (2021), Sci Transl Med, 13
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.
Chowdhury O. et al, (2021), Br J Haematol, 194, 1010 - 1015
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
Salisbury RA. et al, (2021), Leukemia, 35, 2424 - 2430
Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021.
Mughal TI. et al, (2021), Haematologica, 106, 1787 - 1793
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Ahern DJ. et al, (2021)